List of top Radiology Questions on ACR gadolinium contrast groups and NSF risk asked in INI CET

A Group II gadolinium-based contrast agent (per ACR/RCR guidance, lowest risk of nephrogenic systemic fibrosis) can be safely administered in which of the following patients?

According to ACR guidelines, a Group II gadolinium-based contrast agent (lowest risk of nephrogenic systemic fibrosis) can be safely administered in which of the following?